Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Oxidative Phosphorylation Disorders NGS Panel Fulgent Genetics United States | 416 | 235 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 6 |
|
Hearing Loss Advanced Sequencing and CNV Evaluation Athena Diagnostics United States | 249 | 181 |
|
Perrault Syndrome: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 6 | 6 |
|
Blueprint Genetics Finland | 2 | 157 |
|
Comprehensive Hearing Loss and Deafness Panel Blueprint Genetics Finland | 8 | 179 |
|
Blueprint Genetics Finland | 6 | 86 |
|
Neurogenetic Disorders - panels MGZ Medical Genetics Center Germany | 14 | 597 |
|
Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 198 | 157 |
|
Nuclear encoded Mitochondriopathies Panel CeGaT GmbH Germany | 37 | 284 |
|
MGZ Medical Genetics Center Germany | 6 | 168 |
|
Mitochondrial Diseases (mtDNA and 217 nuclear genes) Asper Biogene Asper Biogene LLC Estonia | 89 | 210 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Fulgent Genetics United States | 1103 | 676 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.